LexDanaLexDanabeta
Inventor

Xiben LI

Inventor
US

Overview

5→
Patents
2023–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 5 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
A61KPreparations for medical, dental or toiletry purposes25%
C07DHeterocyclic compounds19%
C07HSugars13%
C07BGeneral methods of organic chemistry6%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium6%
PatentTitleYear
12,552,825C10-alkylene substituted 13-membered macrolides and uses thereof202612,358,921Antiviral heterocyclic compounds202512,162,857Antiviral compounds202411,945,830Antiviral heterocyclic compounds202411,673,910Macrolides with modified desosamine sugars and uses thereof2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2026Patents assigned to HARVARD COLLEGE (2)· patent assignee history
2023–2026Patents assigned to ZIKANI THERAPEUTICS INC (2)· patent assignee history
2023–2026Based in US· patent location history
2024–2025Patents assigned to ENANTA PHARM INC (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ENANTA PHARM INC32024–2025
HARVARD COLLEGE22023–2026
ZIKANI THERAPEUTICS INC22023–2026
Locations
LocationPatentsSpan
US52023–2026